Correction Forthcoming - NuGene International Analyst Brief by BrokerBank Securities, Inc.

May 20, 2015, 07:00 ET from BrokerBank Securities, Inc.

NEW YORK, May 20, 2015 /PRNewswire/ -- NuGene International, Inc. (OTCBB: NUGN) a developer, manufacturer and marketer of advanced skin and hair care lines utilizing adipose derived human stem cells and stem cell media, announced recently the filing of its quarterly report for the three months ended March 31, 2015. During the quarter the company reported $481,360 of sales, relocated to an 11,000 square foot office that acts as a research, manufacturing and assembly location in Orange County, California, invested approximately $83,000 in laboratory and office equipment and leasehold improvements to our new facility, generated all first quarter revenues from the NuGene product lines, effectively diversifying the revenue streams away from affiliated transactions.

For a more detailed research report with analyst comments and recommendation on NuGene International, Inc. please follow the link. There is no cost obligation required to view analyst brief.

http://bit.ly/-NUGN-AnalystBrief

Copy and paste to browser may be required.

FORWARD-LOOKING DISCLAIMER   

This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.  

COMPLIANCE PROCEDURE   

Content is researched, written and reviewed on a best-effort basis. This report was prepared for informational purposes only.  Affiliated parties involved with producing and issuing this report have not been compensated in any form by profiled company.  A full disclaimer can be found by viewing the full analyst report. This document, article or report is written and authored by a 3rd party research analyst. However, we are only human and make mistakes. If you notice any errors or omissions, please notify us below.

BrokerBank Securities, Inc. is a member of the Financial Industry Regulatory Authority, CRD number #130116.

SOURCE BrokerBank Securities, Inc.



RELATED LINKS

http://www.brokerbanksecurities.com